New Content  edit

CME/CE Certified On-Demand
Lecture Series

Upcoming Lectures

There are no meetings currently scheduled in this subject area.
|
Speaker:
Topic:
Format:
Date:
Time:
Location:
Accreditation:


IMPACT Live AML has reached the maximum number of events available to be scheduled. New event requests cannot be accommodated at this time. Please check back soon for future event opportunities.

Novel Frontline Therapy Strategies in Acute Myeloid Leukemia
Learning Objectives:
  • Utilize prognostic implications to inform initial treatment strategies for patients with AML and poor-risk cytogenetics and molecular features
  • Employ current evidence-based recommendations for use of novel chemotherapeutic agents and targeted therapies for induction therapy in fit and less fit patients with AML
  • Employ current evidence-based recommendations for use of novel chemotherapeutic agents and targeted therapies for initial therapy in high-risk patients with AML
  • Describe the common immunologic targets, mechanisms of action, and key efficacy and safety data with various immunotherapeutic therapies in AML

Molecular and Immune Salvage Therapies in Acute Myeloid Leukemia
Learning Objectives:
  • Employ current evidence-based recommendations for use of FLT3 inhibitors relapsed/refractory FLT3-positive AML
  • Utilize current evidence-based recommendations for use of IDH inhibitors in relapsed/refractory IDH-positive AML
  • Use current evidence-based recommendations for use of hypomethylating agents (HMAs) in relapsed/refractory AML
  • Summarize the common immunologic targets, mechanisms of action, and key and safety efficacy data with various immunotherapeutic therapies in AML
  • Describe common toxicities associated with monoclonal antibodies, immune checkpoint inhibitors, and adoptive cell therapies


Accreditation Information

Joint Accreditation Statement
In support of improving patient care, these activities have been planned and implemented by the Postgraduate Institute for Medicine and Total CME.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates each live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates each continuing education activity for 0.5 contact hour (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

Novel Frontline Therapy Strategies in AML- UAN: JA4008162-9999-19-459-L01-P; 0.5 contact hour; Knowledge
Molecular and Immune Salvage Therapies in AML-UAN: JA4008162-9999-19-460-L01-P; 0.5 contact hour; Knowledge

Continuing Nursing Education
The maximum number of hours awarded for each Continuing Nursing Education activity is 0.5 contact hour.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Target Audience
These activities have been designed to meet the educational needs of physicians, registered nurses, pharmacists and other healthcare professionals involved in the care of patients with acute myeloid leukemia (AML).

Fee Information
There is no fee for these educational activities.

Jointly provided by Postgraduate Institute for Medicine and Total CME

These activities are supported by an independent educational grant from Jazz Pharmaceuticals, Inc.



Available Formats

Grand Rounds
Your institution will select a faculty presenter and topic, and provide the in-hospital venue. Rock Solid Meetings and Events with work with an on-site representative to assist with logistical planning as needed.

Dinner Meeting
Held at a restaurant, this program will include the selection of a speaker and topic(s) for a 30-60 minute lecture plus a question-and-answer session. Site selection will comply with ACCME and PhRMA guidelines, and will include a modest meal selection. These are generally private programs for an individual practice group.

Lunch (or breakfast) Meeting
Held at your practice, this program includes a 30-60 minute lecture plus a question-and-answer session. This format will include a modest meal selection, compliant with ACCME and PhRMA guidelines. This program may be for a single practice, or multiple practice groups.

Symposium
This format may include multiple speakers and lecture topics.

Pre-work Program/ Post-work Quiz
Live events utilize a closed-loop learning experience by providing pre-work programs and post-work quizzes to accompany the lecture events to ensure attendees of the lectures retain concepts taught. The flipped classroom pre-work episodes are developed specifically to introduce key information which may be applied during the live event and encourage engagement between the attendee and faculty. Pre-work is presented by expert faculty in several short, educational episodes. Post-work quizzes allow attendees to revisit topics for a better long-term retention and test their knowledge on concepts taught at the lecture.

Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Madonna McDonald prior to the live event at 206.890.0644.

Compliance with Sunshine Act
The National Physician Payment Transparency Program (Sunshine Act) is a section of the Patient Protection and Affordable Care Act of 2010 that requires pharmaceutical and medical device companies to report to the Federal government certain payments (e.g. meals and other meeting expenses) they make to physicians and teaching hospitals. IMPACT Live programs fully comply with the Sunshine Act and, as a result, payments may be reportable based upon these requirements. For detailed information, please visit www.cms.gov.



IMPACT LIVE AML Faculty

Program Chair
Naval Daver, MD
Associate Professor
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Prithviraj Bose, MD
Assistant Professor, Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX
 

John Mascarenhas, MD
Assistant Professor of Medicine
Tisch Cancer Institute - Icahn School of Medicine at Mount Sinai
New York, NY

     

Nikolai Podoltsev, MD, PhD
Assistant Professor, Division of Medicine
Department of Internal Medicine, Hematology Section
Associate Director of the Hematology/Oncology Fellowship Program
Yale University School of Medicine
New Haven, CT

 

Daniel A. Pollyea, MD
Assistant Professor, Clinical Director of Leukemia Services
Department of Medicine, Division of Hematology
University of Colorado
Denver, CO

     
Raajit K. Rampal, MD
Assistant Attending Physician, Leukemia Service
Memorial Sloan-Kettering Cancer Center
New York, NY
 

Bart Scott, MD
Fred Hutchinson Cancer Research Center
University of Washington
Seattle Cancer Care Alliance
Seattle, WA